MK-1084

Note: All products of the company are for scientific research only, and do not
provide products and services for any individual

CAS 2641216-67-1 Cat No JKN03248
Name MK-1084
Synonyms MK-1084
Smiles
CC1CN(C(CN1C(=O)C=C)C)C2=NC(=O)N3C4=C(C=CN=C4C , (C)C)OCCOC5=C(C=CC(=C5C6=C(C=C2C3
=N6)Cl)F)F
Chemical Name 19-chloro-22-(2,5-dimethyl-4-prop-2-enoylpiperazin , -1-yl)-13,16-
difluoro-3-propan-2-yl-8,11-dioxa , -1,4,23,26-
tetrazapentacyclo[16.6.2.02,7.012,1 , 7.021,25]hexacosa-
2(7),3,5,12,14,16,18,20,22,2 , 5-decaen-24-one
Formula C32H31ClF2N6O4 MWt 637.1
Purity 98% Storage Store at 4--8℃
Description MK-1084 is a selective KRAS G12C inhibitor currently in Phase I
clinical trials

At Jingkangen Biomedical, we focus on the discovery, synthesis, and supply of
advanced signaling pathway drugs that support pharmaceutical R&D and
biomedical research. Our expertise in JKN Signaling pathway solutions enables
scientists to explore key molecular mechanisms and accelerate the development
of innovative therapeutics.

Explore Our Signaling Pathway Portfolio
Signaling pathways play a crucial role in regulating cellular activities such
as growth, apoptosis, immune response, and disease progression. To meet the
diverse needs of global researchers, Jingkang en Biomedical provides a wide
range of signaling pathway modulators and related compounds, designed for
both academic research and drug development.

Pathway-specific small molecules – high-purity reagents to target oncology,
immunology, neurology, and metabolic diseases.

Custom synthesis services – tailored solutions for new drug targets and
pathway exploration.

Reference compounds & intermediates – ensuring reproducibility and
reliability in research.

Discover more products: Our Products

Click to Enlarge